MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Dexcom launches Stelo over-the-counter CGM

Dexcom launches Stelo over-the-counter CGM

By

Dexcom Stelo worn by pickleball player
A pickleball player wears the Stelo over-the-counter CGM. [Image courtesy of Dexcom]
Dexcom (Nasdaq: DXCM) today announced a significant product launch as another continuous glucose monitor (CGM) is hitting the market.

Our sister site, Drug Delivery Business News, reported today that Dexcom launched its Stelo over-the-counter (OTC) CGM biosensor.

The San Diego-based company designed Stelo, a small, wearable sensor, specifically for people with type 2 diabetes who do not use insulin. Stelo features a 15-day wear based on the G7 platform. It offers a software experience tailored specifically for non-insulin users.

Dexcom said Stelo makes it easier for the target population to access CGM and offers an option for those who don’t have insurance coverage for CGM.

Get the full story at our sister site, Drug Delivery Business News.

More recent news

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].